WAT
Waters Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Strong buy
+55/100
Last price
436.43
▼ 3.69 (0.84%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
440.30
Prev close
440.12
Day high
454.50
Day low
431.62
Volume
1.06M
Market cap
$42.85B
P/E (TTM)
110.49
52W range
282.77 – 454.54
Day trading desk
Gap from prior close
+0.04%
Prior close 440.12
VWAP
436.79
-0.08% from price
Relative volume
3.32×
Unusually busy
Session range
5.31%
431.61 – 454.54
Position in range
21%
Near session low
ATR (14D)
12.95
2.97% of price
Prior day high
440.79
PDH
Prior day low
423.03
PDL
Bid / ask spread
—
Quote not published
Session volume
2.56M
Avg 770.67K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.54%
-3.5%
1M
+6.61%
+5.5%
3M
+18.55%
+14.0%
6M
+41.98%
+23.8%
YTD
+14.90%
+0.7%
1Y
+32.90%
+16.5%
3Y
+59.16%
-23.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on WAT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+130
Net buying
Buy transactions
3
3.76K shares
Sell transactions
1
3.63K shares
Net transactions
+4
Buys less sells
Sell : buy shares
1.0 : 1
Mixed
Insider-held shares
102.18K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 6, 26 | KUEBLER CHRISTOPHER A Director |
SELL | 3.63K | $1.44M | Direct |
| Aug 6, 26 | KUEBLER CHRISTOPHER A Director |
CONVERSION | 3.63K | $494.69K | Direct |
| Jun 30, 26 | KNIGHT HEATHER Director |
STOCK | 63 | $0 | Direct |
| Jun 30, 26 | JIANG WEI Director |
STOCK | 67 | $0 | Direct |
| Mar 31, 26 | KNIGHT HEATHER Director |
STOCK | 68 | $0 | Direct |
| Mar 31, 26 | JIANG WEI Director |
STOCK | 64 | $0 | Direct |
| Mar 16, 26 | JIANG WEI Director |
BUY | 500 | $144.73K | Direct |
| Mar 6, 26 | FEARON RICHARD H Director |
BUY | 1.00K | $306.34K | Direct |
| Feb 25, 26 | FEARON RICHARD H Director |
STOCK | 23 | $0 | Direct |
| Feb 25, 26 | KNIGHT HEATHER Director |
STOCK | 23 | $0 | Direct |
| Feb 25, 26 | CARPIO ROBERT L III Officer |
STOCK | 997 | $0 | Direct |
| Feb 25, 26 | FRASER CLAIRE Director |
STOCK | 358 | $0 | Direct |
| Feb 25, 26 | VERGNANO MARK P Director |
STOCK | 23 | $0 | Direct |
| Feb 25, 26 | BRENNAN DANIEL J Director |
STOCK | 23 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BATRA UDIT |
Chief Executive Officer | 36.56K | Stock Award(Grant) |
BENNETT JIANQING |
Officer | 7.24K | Stock Award(Grant) |
CARPIO ROBERT L III |
Officer | 3.62K | Stock Award(Grant) |
CHAUBAL AMOL |
Chief Financial Officer | 8.51K | Stock Award(Grant) |
FEARON RICHARD H |
Director | 3.30K | Purchase |
HUANG PEARL S. |
Director | 3.28K | Stock Award(Grant) |
JIANG WEI |
Director | 3.57K | Stock Award(Grant) |
KUEBLER CHRISTOPHER A |
Director | 17.81K | Sale |
ORNSKOV FLEMMING |
Director | 5.27K | Stock Award(Grant) |
VERGNANO MARK P |
Director | 4.54K | Stock Award(Grant) |
Fundamentals
Market cap$42.85B
Enterprise value$47.82B
Revenue (TTM)$4.64B
Gross profit$2.62B
EBITDA$1.45B
Net income$166.63M
EPS (TTM)$3.95
Free cash flow$-142.07M
Total cash$539.00M
Total debt$5.48B
Book value / share$154.70
Shares outstanding98.19M
Float98.07M
Short % of float3.37%
Dividend yield0.00%
Beta (5Y)1.15
Valuation & profitability ratios
Trailing P/E110.49
Forward P/E26.39
PEG ratio1.64
Price / sales—
Price / book2.82
EV / revenue10.30
EV / EBITDA32.93
Gross margin56.34%
Operating margin9.42%
Profit margin3.59%
Return on equity1.92%
Return on assets3.56%
Debt / equity36.05
Current ratio1.86
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.17B | $2.96B | $2.96B | $2.97B | +7.0% |
| Operating revenue | $3.17B | $2.96B | $2.96B | $2.97B | +7.0% |
| Cost of revenue | $1.29B | $1.20B | $1.20B | $1.25B | +7.4% |
| Gross profit | $1.88B | $1.76B | $1.76B | $1.72B | +6.7% |
| Research & development | $195.71M | $183.03M | $174.94M | $176.19M | +6.9% |
| Selling, general & admin | $830.37M | $690.15M | $736.01M | $658.03M | +20.3% |
| Total operating expense | $1.07B | $920.26M | $943.52M | $840.58M | +16.7% |
| Operating income | $802.59M | $837.92M | $817.68M | $883.19M | -4.2% |
| Net interest income | -$50.77M | -$72.26M | -$82.24M | -$37.78M | +29.7% |
| Pre-tax income | $754.88M | $754.87M | $736.24M | $837.85M | +0.0% |
| Tax provision | $112.25M | $117.03M | $94.01M | $130.09M | -4.1% |
| Net income | $642.63M | $637.83M | $642.23M | $707.75M | +0.8% |
| Net income to common | $642.63M | $637.83M | $642.23M | $707.75M | +0.8% |
| Basic EPS | 10.80 | 10.75 | 10.87 | 11.80 | +0.5% |
| Diluted EPS | 10.76 | 10.71 | 10.84 | 11.73 | +0.5% |
| EBIT | $824.43M | $844.54M | $835.10M | $886.64M | -2.4% |
| EBITDA | $1.03B | $1.04B | $1.00B | $1.02B | -0.6% |
| Basic shares | 59.51M | 59.33M | 59.08M | 59.98M | +0.3% |
| Diluted shares | 59.71M | 59.55M | 59.27M | 60.33M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $587.83M | $325.36M | $395.08M | $480.53M | +80.7% |
| Cash & short-term investments | $587.83M | $325.36M | $395.97M | $481.39M | +80.7% |
| Accounts receivable | $828.84M | $733.37M | $702.17M | $722.89M | +13.0% |
| Inventory | $572.37M | $477.26M | $516.24M | $455.71M | +19.9% |
| Total current assets | $2.15B | $1.67B | $1.75B | $1.76B | +28.7% |
| Property, plant & equipment | $722.81M | $725.39M | $723.66M | $668.72M | -0.4% |
| Goodwill & intangibles | $1.90B | $1.86B | $1.93B | $657.73M | +1.9% |
| Total assets | $5.08B | $4.55B | $4.63B | $3.28B | +11.5% |
| Total current liabilities | $1.24B | $789.76M | $789.58M | $785.74M | +56.9% |
| Current debt | $460.00M | — | $50.00M | $50.00M | — |
| Long-term debt | $947.45M | $1.63B | $2.31B | $1.52B | -41.7% |
| Total debt | $1.49B | $1.70B | $2.44B | $1.66B | -12.4% |
| Total liabilities | $2.52B | $2.73B | $3.48B | $2.78B | -7.7% |
| Retained earnings | $10.43B | $9.79B | $9.15B | $8.51B | +6.6% |
| Shareholder equity | $2.56B | $1.83B | $1.15B | $504.49M | +40.1% |
| Working capital | $908.15M | $879.35M | $963.29M | $978.17M | +3.3% |
| Net tangible assets | $662.98M | -$35.12M | -$784.29M | -$153.24M | +1,987.8% |
| Shares issued | 163.16M | 162.96M | 162.71M | 162.43M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $642.63M | $637.83M | $642.23M | $707.75M | +0.8% |
| Depreciation & amortisation | $206.24M | $191.82M | $165.91M | $130.42M | +7.5% |
| Stock-based compensation | $54.13M | $44.71M | $36.87M | $42.56M | +21.1% |
| Change in working capital | -$233.38M | -$111.37M | -$240.26M | -$247.10M | -109.6% |
| Operating cash flow | $652.55M | $762.12M | $602.81M | $611.66M | -14.4% |
| Capital expenditure | -$112.75M | -$142.48M | -$160.63M | -$183.46M | +20.9% |
| Investing cash flow | -$152.25M | -$143.09M | -$1.44B | -$107.97M | -6.4% |
| Share buybacks | -$14.67M | -$13.54M | -$70.28M | -$626.06M | -8.3% |
| Financing cash flow | -$237.21M | -$696.67M | $754.95M | -$509.63M | +66.0% |
| Free cash flow | $539.81M | $619.64M | $442.18M | $428.20M | -12.9% |
| End cash position | $587.83M | $325.36M | $395.08M | $480.53M | +80.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.65B | $1.27B | $932.36M | $799.89M | $771.00M | +29.8% |
| Operating revenue | $1.65B | $1.27B | $932.36M | $799.89M | $771.00M | +29.8% |
| Cost of revenue | $911.00M | $679.00M | $362.86M | $327.81M | $321.00M | +34.2% |
| Gross profit | $734.00M | $588.00M | $569.50M | $472.08M | $450.00M | +24.8% |
| Research & development | $122.00M | $96.00M | $46.90M | $53.64M | $49.00M | +27.1% |
| Selling, general & admin | $405.00M | $387.00M | $240.01M | $214.23M | $198.00M | +4.7% |
| Total operating expense | $771.00M | $635.00M | $298.98M | $279.97M | $259.00M | +21.4% |
| Operating income | -$37.00M | -$47.00M | $270.52M | $192.11M | $191.00M | +21.3% |
| Net interest income | -$55.00M | -$42.00M | -$8.62M | -$21.93M | -$10.00M | -31.0% |
| Pre-tax income | -$141.00M | -$88.00M | $264.18M | $170.12M | $178.00M | -60.2% |
| Tax provision | -$5.00M | -$16.00M | $38.97M | $21.20M | $31.00M | +68.8% |
| Net income | -$136.00M | -$72.00M | $225.21M | $148.92M | $147.00M | -88.9% |
| Net income to common | -$136.00M | -$72.00M | $225.21M | $148.92M | $147.00M | -88.9% |
| Basic EPS | -1.39 | -0.87 | 3.78 | 2.50 | 2.47 | -59.8% |
| Diluted EPS | -1.39 | -0.87 | 3.77 | 2.50 | 2.47 | -59.8% |
| EBIT | -$81.00M | -$40.00M | $278.47M | $196.76M | $193.00M | -102.5% |
| EBITDA | $220.00M | $167.00M | $331.01M | $249.45M | $244.00M | +31.7% |
| Basic shares | 98.20M | 82.14M | 59.55M | 59.53M | 59.52M | +19.6% |
| Diluted shares | 98.20M | 82.14M | 59.76M | 59.62M | 59.66M | +19.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $539.00M | $462.00M | $587.83M | $459.12M | $367.21M | +16.7% |
| Cash & short-term investments | $539.00M | $462.00M | $587.83M | $459.12M | $367.21M | +16.7% |
| Accounts receivable | $1.99B | $1.75B | $828.84M | $748.52M | $730.07M | +13.3% |
| Inventory | $1.38B | $1.50B | $572.37M | $572.94M | $540.75M | -8.0% |
| Total current assets | $4.46B | $4.06B | $2.15B | $1.92B | $1.78B | +9.9% |
| Property, plant & equipment | $1.85B | $1.88B | $722.81M | $713.39M | $724.60M | -1.1% |
| Goodwill & intangibles | $17.94B | $18.09B | $1.90B | $1.91B | $1.92B | -0.8% |
| Total assets | $24.75B | $24.53B | $5.08B | $4.86B | $4.72B | +0.9% |
| Total current liabilities | $2.40B | $2.27B | $1.24B | $1.25B | $1.02B | +5.5% |
| Current debt | $200.00M | $360.00M | $460.00M | $460.00M | $260.00M | -44.4% |
| Long-term debt | $4.89B | $4.86B | $947.45M | $947.21M | $1.20B | +0.6% |
| Total debt | $5.45B | $5.57B | $1.49B | $1.49B | $1.54B | -2.1% |
| Total liabilities | $9.56B | $9.24B | $2.52B | $2.53B | $2.56B | +3.4% |
| Retained earnings | $10.22B | $10.36B | $10.43B | $10.21B | $10.06B | -1.3% |
| Shareholder equity | $15.20B | $15.29B | $2.56B | $2.33B | $2.16B | -0.6% |
| Working capital | $2.07B | $1.79B | $908.15M | $667.89M | $765.99M | +15.4% |
| Net tangible assets | -$2.75B | -$2.80B | $662.98M | $421.56M | $242.78M | +1.9% |
| Shares issued | 98.22M | 201.82M | 163.16M | 163.14M | 163.13M | -51.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$136.00M | -$72.00M | $225.21M | $149.41M | $147.00M | -88.9% |
| Depreciation & amortisation | $301.00M | $207.00M | $52.54M | $52.70M | $51.00M | +45.4% |
| Stock-based compensation | $25.00M | $20.00M | $14.50M | $13.63M | $13.00M | +25.0% |
| Change in working capital | -$258.00M | -$256.00M | -$127.92M | -$9.46M | -$170.00M | -0.8% |
| Operating cash flow | $201.00M | -$3.00M | $164.55M | $187.00M | $41.00M | +6,800.0% |
| Capital expenditure | -$48.00M | -$39.00M | -$38.97M | -$24.77M | -$23.00M | -23.1% |
| Investing cash flow | $2.00M | $95.00M | -$42.13M | -$25.12M | -$59.00M | -97.9% |
| Share buybacks | -$2.00M | -$12.00M | -$144.00K | -$523.00K | $0 | +83.3% |
| Financing cash flow | -$124.00M | -$213.00M | $3.34M | -$66.54M | -$1.00M | +41.8% |
| Free cash flow | $153.00M | -$42.00M | $125.58M | $162.23M | $18.00M | +464.3% |
| End cash position | $539.00M | $462.00M | $587.83M | $459.12M | $367.00M | +16.7% |
Options analytics
Put / call volume
0.64
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
260.00
-40.4% from spot
ATM implied vol
1.6%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
39
Contracts, this expiry
Put volume
25
Contracts, this expiry
Heaviest call OI
370.00
0 contracts
Heaviest put OI
260.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 3.01 | 3.05 | +1.4% |
| Mar 2026 | 2.31 | 2.70 | +17.0% |
| Dec 2025 | 4.51 | 4.53 | +0.5% |
| Sep 2025 | 3.22 | 3.40 | +5.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 4.00 | 21 | $1.75B | +119.3% |
| Next quarter | 4.68 | 20 | $1.79B | +91.7% |
| Current year | 14.58 | 24 | $6.47B | +104.3% |
| Next year | 16.54 | 24 | $7.14B | +10.4% |
Analyst targets & ownership
Mean target$453.26
High target$515.00
Low target$349.00
Implied upside3.86%
Analyst count23
ConsensusBUY
Strong buy / Buy3 / 15
Hold6
Sell / Strong sell0 / 0
Held by insiders0.10%
Held by institutions102.08%
Institutions holding1.61K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
433.73
+0.62% from price
SMA 20
424.94
+2.70% from price
SMA 50
412.80
+5.73% from price
SMA 100
388.48
+12.34% from price
SMA 200
364.15
+19.85% from price
EMA 12
431.30
+1.19% from price
EMA 26
423.85
+2.97% from price
EMA 50
412.24
+5.87% from price
RSI (14)
58.8
Neutral
MACD (12,26,9)
7.45
Hist 0.09
ATR (14)
12.95
2.97% of price
Realised vol 30D
24.1%
Annualised
Bollinger upper
449.18
20, 2σ
Bollinger lower
400.71
20, 2σ
50 / 200 cross
Golden
412.80 vs 364.15
Trend bias
Above 200
+19.85%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.84
Less volatile than market
Correlation to SPY
0.31
Loosely linked
Realised vol 30D
24.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-31.3%
Peak to trough
Max drawdown 5Y
-36.5%
Peak to trough
ATR 14
12.95
2.97% of price
Beta (reported)
1.15
5Y monthly, from filing
Short interest
Shares short
3.30M
Prior 3.64M
Change vs prior
-9.1%
Shorts covering
% of float
3.37%
Normal
% of shares out
3.36%
Against total outstanding
Days to cover
5.1
Crowded exit
Float
98.07M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Sep 21, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Sep 9, 26 | UBS | UPGRADE | Neutral | Buy |
| Aug 27, 26 | Piper Sandler | UPGRADE | Neutral | Overweight |
| Aug 10, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 5, 26 | TD Cowen | UPGRADE | Hold | Buy |
| Aug 5, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 5, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Aug 5, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 5, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 14, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Jul 9, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend dateNov 26, 1996
Next pay date—
Last split2:1
Split dateAug 28, 2000
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-21
Periodic Financial Reports
10-Q · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-08-04
Annual report of employee stock purchase
11-K · 2026-06-25
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-22
Periodic Financial Reports
10-Q · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-05-05
Headlines
Barclays Adjusts Waters Price Target to $500 From $460, Maintains Overweight Rating
MT Newswires · 16h ago
CellCarta, Waters Corporation collaborate on companion diagnostics
Medical Device Network · 18h ago
CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development
PR Newswire · 2d ago
Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call
PR Newswire · 6d ago
Guggenheim Adjusts Price Target on Waters to $490 From $440, Keeps Buy Rating
MT Newswires · 6d ago
1 Volatile Stock with Promising Prospects and 2 We Avoid
StockStory · 7d ago
The Bull Case For Waters (WAT) Could Change Following New At-Home HPV And Cell Analysis Push
Simply Wall St. · 9d ago
Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum
MarketBeat · 10d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.